Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Mar RiveiroAna Barreira-DíazJudit Vidal-GonzálezEva Muñoz-CouseloFernando Martínez-ValleLluís ViladomiuBeatriz MínguezCarolina Ortiz-VelezLluís CastellsRafael EstebanMaría ButiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Immune-related hepatitis can lead to acute liver failure, with absence of increased values of IgG and ANAs. In contrast to autoimmune hepatitis, initial corticosteroids dose were higher, duration shorter with few requiring additional immunosuppression. Retreatment with CPI was not associated with recurrence.